GS
PFE icon

GTS Securities’s Pfizer PFE Stock Holding History

GTS Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
14,176
-403
-3% -$10.5K 0.01% 912
2026
Q1 		$409K Sell
14,579
-42,781
-75% -$1.14M 0.01% 872
2025
Q4 		$1.43M Buy
57,360
+22,493
+65% +$567K 0.05% 310
2025
Q3 		$888K Buy
+34,867
New +$861K 0.03% 474
2025
Q2 		– Sell
-52,679
Closed -$1.33M – 1509
2025
Q1 		$1.33M Buy
52,679
+8,227
+19% +$215K 0.06% 286
2024
Q4 		$1.18M Sell
44,452
-753,645
-94% -$20.4M 0.06% 288
2024
Q3 		$23.1M Sell
798,097
-198,068
-20% -$5.78M 0.05% 224
2024
Q2 		$27.9M Sell
996,165
-326,358
-25% -$8.99M 0.06% 190
2024
Q1 		$36.7M Sell
1,322,523
-127,788
-9% -$3.55M 0.07% 148
2023
Q4 		$41.8M Buy
1,450,311
+509,658
+54% +$15.4M 0.07% 160
2023
Q3 		$31.2M Buy
940,653
+150,269
+19% +$5.31M 0.06% 205
2023
Q2 		$29M Buy
+790,384
New +$30.8M 0.92% 18

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GTS Securities's PFE Position: Q2 2026 in Review

GTS Securities reduced its Pfizer (PFE) stake by 2.8% in Q2 2026, selling an estimated $10.5K and leaving 14,176 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #912.

GTS Securities first reported a position in PFE in Q2 2023 and has held it in 12 quarters since. The position peaked at $41.8M in Q4 2023. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • GTS Securities held 14,176 shares of Pfizer worth $341K as of Q2 2026.
  • GTS Securities sold 403 Pfizer shares in Q2 2026, an estimated $10.5K.
  • Pfizer made up 0.01% of GTS Securities's portfolio in Q2 2026, its #912 holding.
  • GTS Securities first reported a position in Pfizer in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Pfizer position peaked at $41.8M in Q4 2023.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.